Kidney biopsy for the diagnosis and treatment of kidney diseases. Recommendations from the French speaking Society of Nephrology (SFNDT) and French National Authority for Health (HAS) 2022
Nephrol Ther. 2024 Feb 21;20(1):1-20. doi: 10.1684/ndt.2024.68. Online ahead of print.ABSTRACTKidney Biopsy (KB) is a crucial diagnostic tool in the field of renal diseases and is routinely performed in nephrology departments. A previous survey conducted by the Société Francophone de Néphrologie Dialyse Transplantation (SFNDT) revealed significant disparities in clinical practices, sometimes conflicting with the existing literature and recently published recommendations. In response, the SFNDT wished to promote the development of best practice guidelines, under the auspices of the French National Authority for Health (H...
Source: Nephrologie and Therapeutique - February 21, 2024 Category: Urology & Nephrology Authors: Louis de Laforcade Micka ël Bobot Jean-Jacques Boffa Christophe Bovy Claire Cartery Dominique Chauveau Victor Gueutin Corinne Isnard-Bagnis No émie Jourde Chiche Alexandre Karras Aim èle Meftah Clotilde M üller Pierre Si é Thomas Stehl é Laurence Vr Source Type: research
Kidney biopsy for the diagnosis and treatment of kidney diseases. Recommendations from the French speaking Society of Nephrology (SFNDT) and French National Authority for Health (HAS) 2022
Nephrol Ther. 2024 Feb 21;20(1):1-20. doi: 10.1684/ndt.2024.68. Online ahead of print.ABSTRACTKidney Biopsy (KB) is a crucial diagnostic tool in the field of renal diseases and is routinely performed in nephrology departments. A previous survey conducted by the Société Francophone de Néphrologie Dialyse Transplantation (SFNDT) revealed significant disparities in clinical practices, sometimes conflicting with the existing literature and recently published recommendations. In response, the SFNDT wished to promote the development of best practice guidelines, under the auspices of the French National Authority for Health (H...
Source: Nephrologie and Therapeutique - February 21, 2024 Category: Urology & Nephrology Authors: Louis de Laforcade Micka ël Bobot Jean-Jacques Boffa Christophe Bovy Claire Cartery Dominique Chauveau Victor Gueutin Corinne Isnard-Bagnis No émie Jourde Chiche Alexandre Karras Aim èle Meftah Clotilde M üller Pierre Si é Thomas Stehl é Laurence Vr Source Type: research
The highlights of dialysis in 2023
Nephrol Ther. 2024 Feb 12;20(S1):1-11. doi: 10.1684/ndt.2024.66. Online ahead of print.ABSTRACTThere has been a wealth of new developments in dialysis this year with the publication of several trials relating to dialysis technique, physical activity and the use of new dialysis treatments. Quality of life should be assessed and managed in all dialysis patients. Lowering the temperature of the dialysis bath in the MyTemp trial does not appear to have an effect on mortality and cardiovascular events. High volume convective hemodiafiltration currently represents the reference technique in hemodialysis; the Convince study confi...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Stanislas Bataille Nodimar C éline Source Type: research
The highlights in nephrology in 2023
This article aims to summarize the “Quoi de neuf en néphrologie?” session held at the 2023 SFNDT Congress in Liège and sessions focused on updates regarding IgA nephropathy (NIgA) and ANCA-associated vasculitis. The agenda for the nephrology “Quoi de neuf en néphrologie?” session this year was to review key publications from non-nephrology journals, discussing topics such as nephroprotection, treatment of glomerulopathies (IgA and APOL1), clinical trials on arterial hypertension, urinary lithiasis, and other areas of renal physiology, including glomerular filtration rate estimation.PMID:38345208 | DOI:10.1684/nd...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Micka ël Bobot Sandrine Lemoine Source Type: research
The highlights of dialysis in 2023
Nephrol Ther. 2024 Feb 12;20(S1):1-11. doi: 10.1684/ndt.2024.66. Online ahead of print.ABSTRACTThere has been a wealth of new developments in dialysis this year with the publication of several trials relating to dialysis technique, physical activity and the use of new dialysis treatments. Quality of life should be assessed and managed in all dialysis patients. Lowering the temperature of the dialysis bath in the MyTemp trial does not appear to have an effect on mortality and cardiovascular events. High volume convective hemodiafiltration currently represents the reference technique in hemodialysis; the Convince study confi...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Stanislas Bataille Nodimar C éline Source Type: research
The highlights in nephrology in 2023
This article aims to summarize the “Quoi de neuf en néphrologie?” session held at the 2023 SFNDT Congress in Liège and sessions focused on updates regarding IgA nephropathy (NIgA) and ANCA-associated vasculitis. The agenda for the nephrology “Quoi de neuf en néphrologie?” session this year was to review key publications from non-nephrology journals, discussing topics such as nephroprotection, treatment of glomerulopathies (IgA and APOL1), clinical trials on arterial hypertension, urinary lithiasis, and other areas of renal physiology, including glomerular filtration rate estimation.PMID:38345208 | DOI:10.1684/nd...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Micka ël Bobot Sandrine Lemoine Source Type: research
The highlights of dialysis in 2023
Nephrol Ther. 2024 Feb 12;20(S1):1-11. doi: 10.1684/ndt.2024.66. Online ahead of print.ABSTRACTThere has been a wealth of new developments in dialysis this year with the publication of several trials relating to dialysis technique, physical activity and the use of new dialysis treatments. Quality of life should be assessed and managed in all dialysis patients. Lowering the temperature of the dialysis bath in the MyTemp trial does not appear to have an effect on mortality and cardiovascular events. High volume convective hemodiafiltration currently represents the reference technique in hemodialysis; the Convince study confi...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Stanislas Bataille Nodimar C éline Source Type: research
The highlights in nephrology in 2023
This article aims to summarize the “Quoi de neuf en néphrologie?” session held at the 2023 SFNDT Congress in Liège and sessions focused on updates regarding IgA nephropathy (NIgA) and ANCA-associated vasculitis. The agenda for the nephrology “Quoi de neuf en néphrologie?” session this year was to review key publications from non-nephrology journals, discussing topics such as nephroprotection, treatment of glomerulopathies (IgA and APOL1), clinical trials on arterial hypertension, urinary lithiasis, and other areas of renal physiology, including glomerular filtration rate estimation.PMID:38345208 | DOI:10.1684/nd...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Micka ël Bobot Sandrine Lemoine Source Type: research
The highlights of dialysis in 2023
Nephrol Ther. 2024 Feb 12;20(S1):1-11. doi: 10.1684/ndt.2024.66. Online ahead of print.ABSTRACTThere has been a wealth of new developments in dialysis this year with the publication of several trials relating to dialysis technique, physical activity and the use of new dialysis treatments. Quality of life should be assessed and managed in all dialysis patients. Lowering the temperature of the dialysis bath in the MyTemp trial does not appear to have an effect on mortality and cardiovascular events. High volume convective hemodiafiltration currently represents the reference technique in hemodialysis; the Convince study confi...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Stanislas Bataille Nodimar C éline Source Type: research
The highlights in nephrology in 2023
This article aims to summarize the “Quoi de neuf en néphrologie?” session held at the 2023 SFNDT Congress in Liège and sessions focused on updates regarding IgA nephropathy (NIgA) and ANCA-associated vasculitis. The agenda for the nephrology “Quoi de neuf en néphrologie?” session this year was to review key publications from non-nephrology journals, discussing topics such as nephroprotection, treatment of glomerulopathies (IgA and APOL1), clinical trials on arterial hypertension, urinary lithiasis, and other areas of renal physiology, including glomerular filtration rate estimation.PMID:38345208 | DOI:10.1684/nd...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Micka ël Bobot Sandrine Lemoine Source Type: research
The highlights of dialysis in 2023
Nephrol Ther. 2024 Feb 12;20(S1):1-11. doi: 10.1684/ndt.2024.66. Online ahead of print.ABSTRACTThere has been a wealth of new developments in dialysis this year with the publication of several trials relating to dialysis technique, physical activity and the use of new dialysis treatments. Quality of life should be assessed and managed in all dialysis patients. Lowering the temperature of the dialysis bath in the MyTemp trial does not appear to have an effect on mortality and cardiovascular events. High volume convective hemodiafiltration currently represents the reference technique in hemodialysis; the Convince study confi...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Stanislas Bataille Nodimar C éline Source Type: research
The highlights in nephrology in 2023
This article aims to summarize the “Quoi de neuf en néphrologie?” session held at the 2023 SFNDT Congress in Liège and sessions focused on updates regarding IgA nephropathy (NIgA) and ANCA-associated vasculitis. The agenda for the nephrology “Quoi de neuf en néphrologie?” session this year was to review key publications from non-nephrology journals, discussing topics such as nephroprotection, treatment of glomerulopathies (IgA and APOL1), clinical trials on arterial hypertension, urinary lithiasis, and other areas of renal physiology, including glomerular filtration rate estimation.PMID:38345208 | DOI:10.1684/nd...
Source: Nephrologie and Therapeutique - February 12, 2024 Category: Urology & Nephrology Authors: Micka ël Bobot Sandrine Lemoine Source Type: research
Access to kidney transplantation for patients with end-stage renal failure in Maghreb countries: state of art and recommendations
In conclusion, access to transplantation remains low in the Maghreb countries. All the modalities (living donor with enlargement of the circle of donors, deceased donors) must be further developed. Recommendations were issued to support activity.PMID:38314548 | DOI:10.1684/ndt.2024.62 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - February 5, 2024 Category: Urology & Nephrology Authors: Macher Marie-Alice Bacha Mohamed Mongi Soualmia Amel Laouad Inass Sfar Imen Jacquelinet Christian Me çabih Fateh Younous Said Bayar Rached Ziadi Jalel Nebab Abed El Kader Barry Na ïma Nouvellon H élène Gozzerino Agathe Durin Laurent Ben Abdallah Taieb Source Type: research
Geographical access to hemodialysis: an analysis of patient choices
CONCLUSION: The links between the first team and the next one should be strengthened.PMID:38294262 | DOI:10.1684/ndt.2024.59 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - January 31, 2024 Category: Urology & Nephrology Authors: B énédicte Devictor Adeline Cr émades Ghizlane Izaaryene Franck Mazoue Philippe Brunet St éphanie Gentile Source Type: research
Standardization of the management of rheumatoid purpura nephropathy in the West of France. What are the repercussions on the renal sequelae?
CONCLUSION: The protocol allowed a standardization of practices without deleterious consequences at 2 years of follow-up and a decrease in renal biopsy punctures. It is in agreement with the recommendations of KDIGO (Kidney Disease Improving Global Outcomes) and European experts. On the other hand, in view of recent studies and the physiopathology, immunosuppressive drugs other than corticosteroids could be introduced earlier in severe forms.PMID:38294263 | DOI:10.1684/ndt.2024.65 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - January 31, 2024 Category: Urology & Nephrology Authors: Margaux Salmon Chlo é Rousseau Gwena ëlle Roussey Nadine Jay Sylvie Cloarec Maud Injeyan Am élie Ryckewaert Sophie Taque Source Type: research
